Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats: Temporal regulation and spatial heterogeneity

Hypertension

Volumn 34, Issue 2, 1999, Pages 229-235

  Tea, Bun Seng ^b   Dam, Than Vinh ^b   Moreau, Pierre ^b   Hamet, Pavel ^b   DeBlois, Denis ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

ACE inhibitor; AT1 antagonist; Calcium channel blocker; adrenergic antagonist

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LOSARTAN; NIFEDIPINE; PROPRANOLOL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DNA CONTENT; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HEART HYPERTROPHY; HEART RATE; HEART WORK; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0032858327     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.2.229     Document Type: Article

References (44)

1. Agabiti-Rosei E. Evaluation of the cardiac effects of antihypertensive agents. J Cardiovasc Pharmacol. 1994;23(suppl 5):S42-S48.
2. Walsh RA, Dorn GW II. Growth and hypertrophy of the heart and blood vessels. In: Alexander RW, Schlant RC, Fuster V, eds. The Heart. New York, NY: McGraw-Hill; 1998:155-168.
3. Thompson GB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
4. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC, Quaini F, Sonnenblick EH, Anversa P. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp Cell Res. 1995;219:110-121.
5. Moreau P, Tea BS, Dam TV, Hamet P. Altered balance between cell replication and apoptosis in hearts and kidneys of newborn SHR. Hypertension. 1997;30:720-724.
6. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara JA, Chapnick S, Reiss K, Olivetti G, Anversa P. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol. 1996;271: H1215-H1228.
7. Hamet P, Richard L, Dam T-V, Teiger E, Orlov SN, Gaboury L, Gossard F, Tremblay J. Apoptosis in target organs of hypertension. Hypertension. 1995;26:642-648.
8. Teiger E, Dam TV, Richard L, Wisnewsky C, Tea BS, Gaboury L, Tremblay J, Schwanz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 1996;97:2891-2897.
9. Diez J, Panizo A, Hemandez M, Vega F, Sola I, Fortuno MA, Pardo J. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension. 1997;30:1029-1034.
10. 1 blockade with losartan. Hypertension. 1998; 32:280-286.
11. Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996;11:245-251. Review.
12. Walter SV, Hamet P. Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats. Hypertension. 1986;8: 520-525.
13. Bing OH, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol. 1995;27:383-396.
14. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 1997;272:H2313-H2319.
15. Diez J, Panizo A, Hernandez M, Pardo J. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension. 1997;29:776-780.
16. deBlois D, Tea B-S, Dam T-V, Tremblay J, Hamet P. Smooth muscle cell apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 1997;29:340-349.
17. Ostman-Smith I. Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat. Br J Pharmacol. 1995;116:2703-2709.
18. Hamet P, Moreau P, Dam T-V, Orlov SN, Tea B-S, deBlois D, Tremblay J. The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. J Hypertens. 1996;14(suppl 5):S65-S70.
19. Tea B-S, Der Sarkissian S, Hamet P, deBlois D. Apoptotic and anti-proliferative role of angiotensin II receptor subtype 2 in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension. 1998; 32:600. Abstract.
20. Igawa T, Ikeno K, Watanabe K, Kimura Y. Dose-related inhibitory effects of the beta-adrenoceptor blocking drug carteolol and propanolol ion cardiac hypertrophy in spontaneously hypertensive rats. Eur J Pharmacol. 1984;104(1-2):93-99.
21. Kobayashi H, Sano T, Tarazi RC, Fouad-Tarazi FM. Effects of antihypertensive drugs on heart and resistance vessels. Cardiovasc Res. 1990; 24:137-143.
22. Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res. 1995;30: 537-543. Review.
23. Beinlich CJ, Rissinger CJ, Morgan HE. Mechanisms of rapid growth in the neonatal pig heart. J Mol Cell Cardiol. 1995;27:273-281.
24. Campbell SE, Turek Z, Rakusan K, Kazda S. Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine. Cardiovasc Res. 1993;27:1350-1358.
25. Gerdes AM, Moore JA, Hines JM. Regional changes in myocyte size and number in propranolol-treated hyperthyroid rats. Lab Invest. 1987;57: 708-713.
26. Lejemtel TH, Sonnenblick EH, Frishman WH, Diagnosis and management of heart failure. In: Alexander RW, Schlant RC, Fuster V. The Heart. New York. NY: McGraw-Hill; 1998:745-781.
27. Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Page V, Ghadirian P, LeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 1996;14:1237-1245.
28. Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, Goldstein S. Sabbah HN. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol. 1998;275:H626-H631.
29. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997;29:859-870.
30. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adull rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 1998;98:1329-1334.
31. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. Beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 1998;275: H961-H968.
32. Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, Anversa P. p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res. 1997;234:57-65.
33. Panizo-Santos A, Sola JJ, Pardo-Mindan FJ, Hernandez M, Cenarruzabeitia E, Diez J. Angiotensin converting enzyme inhibition prevents polyploidization of cardiomyocytes in spontaneously hypertensive rats with left ventricular hypertrophy. J Pathol. 1995;177:431-437.
34. Palmon LC, Reichek N, Yeon SB, Clark NR, Brownson D, Hoffman E, Axel L. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation. 1994;89:122-131.
35. Cook SJ, Chamunorwa JP, Lancaster MK, O'Neill SC. Regional differences in the regulation of intracellular sodium and in action potential configuration in rabbit left ventricle. Pflugers Arch. 1997;433:515-522.
36. Figueredo VM, Brandes R, Weiner MW, Massie BM, Camacho SA. Endocardial versus epicardial differences of intracellular free calcium under normal and ischemic conditions in perfused rat hearts. Circ Res. 1993;72:1082-1090.
37. Lukas A, Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia: role of the transient outward current. Circulation. 1993;88: 2903-2915.
38. Miyoshi S, Miyazaki T, Moritani K, Ogawa S. Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia. Am J Physiol. 1996;271:H140-H147.
39. Yang ZK, Boyett MR, Janvier NC, McMorn SO, Shui Z, Karim F. Regional differences in the negative inotropic effect of acetylcholine within the canine ventricle. J Physiol (Lond). 1996;492:789-806.
40. Clark RB, Bouchard RA, Salinas-Stefanon E, Sanchez-Chapula J, Giles WR. Heterogeneity of action potential waveforms and potassium currents in rat ventricle. Cardiovasc Res. 1993;27:1795-1799.
41. Beau SL, Tolley TK, Saffitz JE. Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts. Circulation. 1993;88:2501-2509.
42. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens. 1997;6:169-176. Review; see comments.
43. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856-869.
44. Anversa P, Zhang X, Li P, Capasso JM. Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J Clin Invest. 1992;89:618-629.